Literature DB >> 32066577

Hyperparathyroidism in pregnancy.

Catherine Davis1, Tanya Nippita2,3.   

Abstract

Hyperparathyroidism is a rare disease during pregnancy, which has increased risks, including miscarriage and fetal growth restriction. However, the diagnosis of hyperparathyroidism is frequently not recognised or delayed as symptoms are non-specific and calcium is not routinely measured. With a thorough medical history and clinical suspicion, early diagnosis and treatment can reduce the risk of some pregnancy complications. A 35-year-old woman presented at 13/40 with hyperemesis gravidarum. She had elevated serum calcium and a parathyroid lesion on ultrasound. She underwent a parathyroidectomy with rapid normalisation of her calcium. Histopathology confirmed a parafibromin-deficient parathyroid tumour, suggestive of hyperparathyroidism jaw tumour syndrome. At 30/40, she presented with pre-eclampsia (hypertension, hyper-reflexia, proteinuria and intrauterine growth restriction) and had a caesarean section at 30+1/40, delivering a male infant, 897 g (fifth percentile). She had a prior 12-month history of chronic constipation and nephrolithiasis but was not investigated further despite elevated calcium (2.82 mmol/L). © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  endocrinology; pregnancy

Mesh:

Substances:

Year:  2020        PMID: 32066577      PMCID: PMC7046386          DOI: 10.1136/bcr-2019-232653

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Hyperparathyroid crisis presenting with hyperemesis gravidarum.

Authors:  Banu Aktaş Yilmaz; Mustafa Altay; Ceyla Konca Değertekin; Ali Riza Çimen; Özlem Turhan Iyidir; Aydan Biri; Osman Yüksel; Füsun Baloş Törüner; Metin Arslan
Journal:  Arch Gynecol Obstet       Date:  2014-06-11       Impact factor: 2.344

Review 2.  Primary hyperparathyroidism during pregnancy.

Authors:  Vincent Dochez; Guillaume Ducarme
Journal:  Arch Gynecol Obstet       Date:  2014-11-04       Impact factor: 2.344

Review 3.  Clinical evidence of the effect of bisphosphonates on pregnancy and the infant.

Authors:  Nikolaos Machairiotis; Georgia Ntali; Paraskevi Kouroutou; Lina Michala
Journal:  Horm Mol Biol Clin Investig       Date:  2019-09-20

4.  Hypercalcemic Pancreatitis Triggered by Pregnancy With a CYP24A1 Mutation.

Authors:  Wilson T Kwong; Syed M Fehmi
Journal:  Pancreas       Date:  2016-07       Impact factor: 3.327

5.  Primary hyperparathyroidism in pregnancy.

Authors:  M Amaya García; M Acosta Feria; A Soto Moreno; E Dios Fuentes; E Navarro González; D Quijada Thong; A Del Valle; D Acosta Delgado; R Astorga Jiménez
Journal:  Gynecol Endocrinol       Date:  2004-08       Impact factor: 2.260

6.  Aromatase inhibitor treatment of menorrhagia and subsequent pregnancy in a patient with familial hyperparathyroidism-jaw tumor syndrome.

Authors:  Erin F Wolff; Micah J Hill; William F Simonds; James H Segars
Journal:  Fertil Steril       Date:  2012-09-08       Impact factor: 7.329

7.  Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention.

Authors:  James Norman; Douglas Politz; Laura Politz
Journal:  Clin Endocrinol (Oxf)       Date:  2008-12-05       Impact factor: 3.478

Review 8.  Calcium homeostasis in pregnancy.

Authors:  D J Hosking
Journal:  Clin Endocrinol (Oxf)       Date:  1996-07       Impact factor: 3.478

Review 9.  Non-surgical management of primary hyperparathyroidism.

Authors:  Filomena Cetani; Federica Saponaro; Claudio Marcocci
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-09-28       Impact factor: 4.690

10.  Hypercalcemia in pregnancy - a multifaceted challenge: case reports and literature review.

Authors:  Evelyne Rey; Claude-Emilie Jacob; Maral Koolian; Francine Morin
Journal:  Clin Case Rep       Date:  2016-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.